Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss - Unaudited

v2.4.0.8
Condensed Consolidated Statements of Operations and Comprehensive Loss - Unaudited (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Statement Of Income And Comprehensive Income [Abstract]        
Product revenue $ 5,998 $ 5,298 $ 17,614 $ 16,604
Costs of revenue 1,939 1,737 5,191 5,012
Operating expenses:        
Research and development 1,970 666 5,602 2,867
General and administrative 2,943 1,193 12,298 4,067
Sales and marketing 4,783 3,720 14,844 12,123
Total operating expenses 9,696 5,579 32,744 19,057
Loss from operations (5,637) (2,018) (20,321) (7,465)
Other income (expense):        
Interest income 3 4 11 13
Interest expense (1,107) (453) (2,191) (1,345)
Loss on extinguishment of debt     (1,596)  
Change in fair value of derivative liabilities 1,887 115 1,325 (150)
Other expense (78) 4 (112) (1)
Total other income (expense) 705 (330) (2,563) (1,483)
Net loss before income taxes (4,932) (2,348) (22,884) (8,948)
Provision for income taxes 0 0 0 0
Net Loss (4,932) (2,348) (22,884) (8,948)
Other comprehensive loss, net of tax:        
Unrealized loss on marketable securities       (2)
Total comprehensive loss $ (4,932) $ (2,348) $ (22,884) $ (8,950)
Net loss per share attributable to common stockholders:        
Basic and diluted $ (0.39) $ (4.11) $ (2.20) $ (17.64)
Weighted average common shares outstanding:        
Basic and diluted 12,689,307 571,645 10,383,228 507,227